actoferrin and lysozyme supplementation for long-term diarrhea sequelae

ational Institute of Health0 个研究点目标入组 600 人开始时间: 2021年8月25日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•An eligible child will be aged 6-24 months
•Child is seen as an inpatient or outpatient for diarrhea who is ready to return home, with a MUAC <12.5 cm at the time of screening
•Child's caregiver consents for study participation
•Caregiver plan to remain in study area with the child for at least 6 months
•Child is not enrolled in another study
•Child is no longer exclusively breastfeeding

•Children younger than 6 months or older than 24 months
•Accompanying caregiver does not provide consent to study participation
•Caregiver reports the child will not stay within the study area for the next 6 months
•Child is enrolled in another study
•Child is exclusively breastfeeding at the time of enrolment
•Child is not yet discharged or discharged against medical advice
•Child has a history of congenital defect or syndrome that prevents age-appropriate feeding (e.g. cleft palate)
•Unwilling to participate in the dual sugar permeability sub-study if selected
•History of allergic reaction to dairy products

发起方

ational Institute of Health